{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:54:51Z","timestamp":1791600891855,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["IZSEZ0_193593"],"award-info":[{"award-number":["IZSEZ0_193593"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although prevention of dementia and late-life cognitive decline is a major public health priority, there are currently no generally established prevention strategies or operational models for implementing such strategies into practice. This article is a narrative review of available evidence from multidomain dementia prevention trials targeting several risk factors and disease mechanisms simultaneously, in individuals without dementia at baseline. Based on the findings, we formulate recommendations for implementing precision risk reduction strategies into new services called Brain Health Services. A literature search was conducted using medical databases (MEDLINE via PubMed and SCOPUS) to select relevant studies: non-pharmacological multidomain interventions (i.e., combining two or more intervention domains), target population including individuals without dementia, and primary outcomes including cognitive\/functional performance changes and\/or incident cognitive impairment or dementia. Further literature searches covered the following topics: sub-group analyses assessing potential modifiers for the intervention effect on cognition in the multidomain prevention trials, dementia risk scores used as surrogate outcomes in multidomain prevention trials, dementia risk scores in relation to brain pathology markers, and cardiovascular risk scores in relation to dementia. Multidomain intervention studies conducted so far appear to have mixed results and substantial variability in target populations, format and intensity of interventions, choice of control conditions, and outcome measures. Most trials were conducted in high-income countries. The differences in design between the larger, longer-term trials that met vs. did not meet their primary outcomes suggest that multidomain intervention effectiveness may be dependent on a precision prevention approach, i.e., successfully identifying the at-risk groups who are most likely to benefit. One such successful trial has already developed an operational model for implementing the intervention into practice. Evidence on the efficacy of risk reduction interventions is promising, but not yet conclusive. More long-term multidomain randomized controlled trials are needed to fill the current evidence gaps, especially concerning low- and middle-income countries and integration of dementia prevention with existing cerebrovascular prevention programs. A precision risk reduction approach may be most effective for dementia prevention. Such an approach could be implemented in Brain Health Services.<\/jats:p>","DOI":"10.1186\/s13195-021-00875-8","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T17:57:14Z","timestamp":1633975034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services\u2014part 4 of 6"],"prefix":"10.1186","volume":"13","author":[{"given":"Alina","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1905-8993","authenticated-orcid":false,"given":"Daniele","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Kulmala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia","family":"Ngandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ribaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Task Force for Brain Health Services","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Brayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brioschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Ch\u00e9telat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Csajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Demonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Dodich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mcwhirter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Minguill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Miniussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Ranson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ribaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"van Duijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"875_CR1","doi-asserted-by":"crossref","unstructured":"Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, et al. Precision prevention of Alzheimer\u2019s and other dementias: anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimer\u2019s Dement. 16:1457\u201368 Wiley; 2020 [cited 2020 Nov 24]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32815289\/.","DOI":"10.1002\/alz.12132"},{"key":"875_CR2","doi-asserted-by":"publisher","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020:413\u201346 Lancet Publishing Group; [cited 2020 Sep 29]. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"875_CR3","unstructured":"Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"4","key":"875_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jnnp-2018-318212","volume":"90","author":"X-H Hou","year":"2019","unstructured":"Hou X-H, Feng L, Zhang C, Cao X-P, Tan L, Yu J-T. Models for predicting risk of dementia: a systematic review. J Neurol Neurosurg Psychiatry. 2019;90(4):373\u20139. https:\/\/doi.org\/10.1136\/jnnp-2018-318212.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"875_CR5","doi-asserted-by":"crossref","unstructured":"Karmali KN, Persell SD, Perel P, Lloyd-Jones DM, Berendsen MA, Huffman MD. Risk scoring for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. Wiley; 2017 [cited 2020 Nov 23]. Available from: http:\/\/doi.wiley.com\/10.1002\/14651858.CD006887.pub4.","DOI":"10.1002\/14651858.CD006887.pub4"},{"key":"875_CR6","doi-asserted-by":"publisher","unstructured":"Altomare D, Molinuevo JL, Ritchie C, Ribaldi F, Carrera E, Dubois B, Jessen F, McWhirter L, Scheltens P, van der Flier WM, Vellas B, D\u00e9monet JF, Frisoni GB. Brain Health Services: Organization, structure and challenges for implementation. A user manual for Brain Health Services \u2013 Part 1 of 6. Alzheimer's Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13195-021-00827-2.","DOI":"10.1186\/s13195-021-00827-2"},{"key":"875_CR7","doi-asserted-by":"publisher","unstructured":"Ranson JM, Rittman T, Hayat S, Brayne C, Jessen F, Blennow K, van Duijn C, Barkhof F, Tang E, Mummery CJ, Stephan BCM, Altomare D, Frisoni GB, Ribaldi F, Molinuevo JL, Scheltens P, Llewellyn, DJ. Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services \u2013 Part 2 of 6. Alzheimer's Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13195-021-00895-4.","DOI":"10.1186\/s13195-021-00895-4"},{"key":"875_CR8","doi-asserted-by":"publisher","unstructured":"Visser LNC, Minguillon C, S\u00e1nchez-Benavides G, Abramowicz M, Altomare D, Fauria K, Frisoni GB, Georges J, Ribaldi F, Scheltens P, van der Schaar J, Zwan M, van der Flier WM, Molinuevo JL. Dementia risk communication. A user manual for Brain Health Services \u2013 Part 3 of 6. Alzheimer's Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13195-021-00840-5.","DOI":"10.1186\/s13195-021-00840-5"},{"key":"875_CR9","doi-asserted-by":"publisher","unstructured":"Brioschi Guevara A, Bieler M, Altomare D, Berthier M, Csajka C, Dautricourt S, D\u00e9monet JF, Dodich A, Frisoni GB, Miniussi C, Molinuevo JL, Ribaldi F, Scheltens P, Ch\u00e9telat G. Protocols for cognitive enhancement. A user manual for Brain Health Services \u2013 Part 5 of 6. Alzheimer's Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13195-021-00844-1.","DOI":"10.1186\/s13195-021-00844-1"},{"key":"875_CR10","doi-asserted-by":"publisher","unstructured":"Milne R, Altomare D, Ribaldi F, Molinuevo JL, Frisoni GB, Brayne C. Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services \u2013 Part 6 of 6. Alzheimer's Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13195-021-00885-6.","DOI":"10.1186\/s13195-021-00885-6"},{"key":"875_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jamainternmed.2013.189","volume":"173","author":"DE Barnes","year":"2013","unstructured":"Barnes DE, Santos-Modesitt W, Poelke G, Kramer AF, Castro C, Middleton LE, et al. The mental activity and exercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med. 2013;173:797\u2013804 [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23545598\/.","journal-title":"JAMA Intern Med"},{"key":"875_CR12","doi-asserted-by":"publisher","first-page":"e76301","DOI":"10.1371\/journal.pone.0076301","volume":"8","author":"CRR Alves","year":"2013","unstructured":"Alves CRR, Merege Filho CAA, Benatti FB, Brucki S, Pereira RMR, de S\u00e1 Pinto AL, et al. Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind study. Blachier F, editor. PLoS One. 2013;8:e76301 Public Library of Science; [cited 2020 Dec 10]. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0076301.","journal-title":"PLoS One"},{"key":"875_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1747-4949.2012.00928.x","volume":"9","author":"H Ihle-Hansen","year":"2014","unstructured":"Ihle-Hansen H, Thommessen B, Fagerland MW, \u00d8kseng\u00e5rd AR, Wyller TB, Engedal K, et al. Multifactorial vascular risk factor intervention to prevent cognitive impairment after stroke and TIA: a 12-month randomized controlled trial. Int J Stroke. 2014;9:932\u20138 Blackwell Publishing Ltd; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23205666\/.","journal-title":"Int J Stroke"},{"key":"875_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jamda.2014.09.010","volume":"15","author":"MA Fiatarone Singh","year":"2014","unstructured":"Fiatarone Singh MA, Gates N, Saigal N, Wilson GC, Meiklejohn J, Brodaty H, et al. The Study of Mental and Resistance Training (SMART) Study-resistance training and\/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial. J Am Med Dir Assoc. 2014;15:873\u201380 Elsevier Inc.; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25444575\/.","journal-title":"J Am Med Dir Assoc"},{"key":"875_CR15","doi-asserted-by":"publisher","unstructured":"Lam LC, Chan WC, Leung T, Fung AW, Leung EM. Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial. PLoS One. 2015;10(3):e0118173. https:\/\/doi.org\/10.1371\/journal.pone.0118173.","DOI":"10.1371\/journal.pone.0118173"},{"issue":"9984","key":"875_CR16","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2\u2009year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5.","journal-title":"Lancet."},{"key":"875_CR17","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1161\/STROKEAHA.115.009992","volume":"46","author":"K Matz","year":"2015","unstructured":"Matz K, Teuschl Y, Firlinger B, Dachenhausen A, Keindl M, Seyfang L, et al. Multidomain lifestyle interventions for the prevention of cognitive decline after ischemic stroke randomized trial. Stroke. 2015;46:2874\u201380 Lippincott Williams and Wilkins; [cited 2020 Sep 29]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26374482\/.","journal-title":"Stroke"},{"key":"875_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","volume":"388","author":"EPM van Charante","year":"2016","unstructured":"van Charante EPM, Richard E, Eurelings LS, van Dalen JW, Ligthart SA, van Bussel EF, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet. 2016;388:797\u2013805 Lancet Publishing Group.","journal-title":"Lancet."},{"issue":"5","key":"875_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","volume":"16","author":"S Andrieu","year":"2017","unstructured":"Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377\u201389. https:\/\/doi.org\/10.1016\/S1474-4422(17)30040-6 Lancet Publishing Group.","journal-title":"Lancet Neurol"},{"key":"875_CR20","first-page":"861","volume":"72","author":"MA Espeland","year":"2017","unstructured":"Espeland MA, Lipska K, Miller ME, Rushing J, Cohen RA, Verghese J, et al. Effects of physical activity intervention on physical and cognitive function in sedentary adults with and without diabetes. J Gerontol A Biol Sci Med Sci. 2017;72:861\u20136 [cited 2020 Sep 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27590629\/.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"875_CR21","volume-title":"The effect of a multicomponent intervention to promote community activity on cognitive function in older adults with mild cognitive impairment: a randomized controlled trial","author":"S Bae","year":"2018","unstructured":"Bae S, Lee S, Lee S, Jung S, Makino K, Harada K, et al. The effect of a multicomponent intervention to promote community activity on cognitive function in older adults with mild cognitive impairment: a randomized controlled trial. 2018; Available from: www.elsevier.com\/locate\/ctim"},{"key":"875_CR22","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1212\/WNL.0000000000006784","volume":"92","author":"JA Blumenthal","year":"2019","unstructured":"Blumenthal JA, Smith PJ, Mabe S, Hinderliter A, Lin PH, Liao L, et al. Lifestyle and neurocognition in older adults with cognitive impairments: a randomized trial. Neurology. 2019;92:E212\u201323 Lippincott Williams and Wilkins. [cited 2020 Dec 10]. Available from: https:\/\/n.neurology.org\/content\/92\/3\/e212.","journal-title":"Neurology"},{"key":"875_CR23","doi-asserted-by":"crossref","unstructured":"McMaster M, Kim S, Clare L, Torres SJ, Cherbuin N, D\u02bcEste C, et al. Lifestyle risk factors and cognitive outcomes from the multidomain dementia risk reduction randomized controlled trial, body brain life for cognitive decline (BBL-CD). J Am Geriatr Soc. 2020:jgs.16762 Blackwell Publishing Inc.;[cited 2020 Sep 29]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgs.16762.","DOI":"10.1111\/jgs.16762"},{"key":"875_CR24","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1001\/jama.2020.16909","volume":"324","author":"HA Bischoff-Ferrari","year":"2020","unstructured":"Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, Da Silva JAP, Blauth M, et al. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324:1855\u201368 American Medical Association; [cited 2020 Dec 9]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33170239\/.","journal-title":"JAMA"},{"key":"#cr-split#-875_CR25.1","doi-asserted-by":"crossref","unstructured":"Kulmala J, Ngandu T, Kivipelto M. Prevention matters: time for global action and effective implementation. J Alzheimer's Dis. 2018:S191-8 IOS Press","DOI":"10.3233\/JAD-179919"},{"key":"#cr-split#-875_CR25.2","unstructured":"[cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29504541\/."},{"issue":"9","key":"875_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5(9):735\u201341. https:\/\/doi.org\/10.1016\/S1474-4422(06)70537-3.","journal-title":"Lancet Neurol"},{"key":"875_CR27","doi-asserted-by":"publisher","unstructured":"Rosenberg A, Ngandu T, Rusanen M, Antikainen R, Backman L, Havulinna S, et al. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial. Alzheimers Dement. 2018;14:263\u201370. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.006.","DOI":"10.1016\/j.jalz.2017.09.006"},{"key":"875_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","volume":"75","author":"A Solomon","year":"2018","unstructured":"Solomon A, Turunen H, Ngandu T, Peltonen M, Lev\u00e4lahti E, Helisalmi S, et al. Effect of the apolipoprotein e genotype on cognitive change during a multidomain lifestyle intervention a subgroup analysis of a randomized clinical trial. JAMA Neurol. 2018;75:462\u201370 American Medical Association; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29356827\/.","journal-title":"JAMA Neurol"},{"key":"875_CR29","doi-asserted-by":"publisher","unstructured":"Deckers K, K\u00f6hler S, Ngandu T, Antikainen R, Laatikainen T, Soininen H, Strandberg T, Verhey F, Kivipelto M, Solomon A. Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index. Alzheimers Dement. 2021;17(7):1205\u201312. https:\/\/doi.org\/10.1002\/alz.12281. Epub 2021 Jan 6.","DOI":"10.1002\/alz.12281"},{"key":"875_CR30","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3233\/JAD-170123","volume":"59","author":"S Sindi","year":"2017","unstructured":"Sindi S, Ngandu T, Hovatta I, K\u2019areholt I, Antikainen R, H\u00e4nninen T, et al. Baseline telomere length and effects of a multidomain lifestyle intervention on cognition: the FINGER randomized controlled trial. J Alzheimer\u2019s Dis. 2017;59:1459\u201370 IOS Press; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28777749\/.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"875_CR31","doi-asserted-by":"publisher","unstructured":"Stephen R, Liu Y, Ngandu T, Antikainen R, Hulkkonen J, Koikkalainen J, Kemppainen N, L\u00f6tj\u00f6nen J, Lev\u00e4lahti E, Parkkola R, Pippola P, Rinne J, Strandberg T, Tuomilehto J, Vanninen R, Kivipelto M, Soininen H, Solomon A; FINGER study group. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER). Alzheimers Res Ther. 2019;11(1):53. https:\/\/doi.org\/10.1186\/s13195-019-0506-z.","DOI":"10.1186\/s13195-019-0506-z"},{"key":"875_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s12603-018-1024-6","volume":"22","author":"M Tabue-Teguo","year":"2018","unstructured":"Tabue-Teguo M, Barreto de Souza P, Cantet C, Andrieu S, Simo N, Foug\u00e8re B, et al. Effect of multidomain intervention, omega-3 polyunsaturated fatty acids supplementation or their combinaison on cognitive function in non-demented older adults according to frail status: results from the MAPT Study. J Nutr Heal Aging. 2018;22:923\u20137 Springer-Verlag France; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30272094\/.","journal-title":"J Nutr Heal Aging"},{"key":"875_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jalz.2019.07.008","volume":"15","author":"J Delrieu","year":"2019","unstructured":"Delrieu J, Payoux P, Carri\u00e9 I, Cantet C, Weiner M, Vellas B, et al. Multidomain intervention and\/or omega-3 in nondemented elderly subjects according to amyloid status. Alzheimer\u2019s Dement. 2019;15:1392\u2013401 Elsevier Inc.; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31558366\/.","journal-title":"Alzheimer\u2019s Dement"},{"key":"875_CR34","doi-asserted-by":"publisher","unstructured":"Chhetri JK, de Souto Barreto P, Cantet C, Pothier K, Cesari M, Andrieu S, et al. Effects of a 3-year multi-domain intervention with or without omega-3 supplementation on cognitive functions in older subjects with increased CAIDE dementia scores. J Alzheimers Dis. 2018;64:71\u20138. https:\/\/doi.org\/10.3233\/JAD-180209.","DOI":"10.3233\/JAD-180209"},{"key":"875_CR35","doi-asserted-by":"publisher","unstructured":"van Middelaar T, Hoevenaar-Blom MP, van Gool WA, Moll van Charante EP, van Dalen JW, Deckers K, et al. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index. Alzheimers Res Ther. 2018;10:62\u20134. https:\/\/doi.org\/10.1186\/s13195-018-0389-4.","DOI":"10.1186\/s13195-018-0389-4"},{"key":"875_CR36","doi-asserted-by":"publisher","unstructured":"Schiepers OJG, Kohler S, Deckers K, Irving K, O\u2019Donnell CA, van den Akker M, et al. Lifestyle for Brain Health (LIBRA): a new model for dementia prevention. Int J Geriatr Psychiatry. 2018;33:167\u201375. https:\/\/doi.org\/10.1002\/gps.4700.","DOI":"10.1002\/gps.4700"},{"key":"875_CR37","doi-asserted-by":"publisher","unstructured":"Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr; Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on \u201cThe Preclinical State of AD\u201d; July 23, 2015; Washington DC, USA. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292\u2013323. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.002.","DOI":"10.1016\/j.jalz.2016.02.002"},{"key":"875_CR38","doi-asserted-by":"publisher","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(14)70090-0. Erratum in: Lancet Neurol. 2014;13(8):757.","DOI":"10.1016\/S1474-4422(14)70090-0"},{"key":"875_CR39","doi-asserted-by":"publisher","unstructured":"O\u2019Donnell CA, Browne S, Pierce M, McConnachie A, Deckers K, van Boxtel MP, et al. Reducing dementia risk by targeting modifiable risk factors in mid-life: study protocol for the Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) randomised controlled feasibility trial. Pilot feasibility Stud. 2015;1:40. https:\/\/doi.org\/10.1186\/s40814--015-0035-x. eCollection2015.","DOI":"10.1186\/s40814--015-0035-x"},{"key":"875_CR40","doi-asserted-by":"publisher","first-page":"P1024","DOI":"10.1016\/j.jalz.2018.06.2798","volume":"14","author":"A Solomon","year":"2018","unstructured":"Solomon A, Lev\u00e4lahti E, Antikainen R, Laatikainen T, Soininen H, Strandberg T, et al. Effects of a multidomain lifestyle intervention on overall risk for dementia: the FINGER randomized controlled trial. Alzheimer\u2019s Dement. 2018;14:P1024\u20135. Elsevier; Available from:. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.2798.","journal-title":"Alzheimer\u2019s Dement"},{"key":"875_CR41","doi-asserted-by":"publisher","unstructured":"Barbera M, Ngandu T, Lehv\u00e4lahti E, Coley N, Mangialasche F, Hoevenaar-Blom M, et al. Effect of multidomain interventions on estimated dementia and cardiovascular risk reduction: an individual-participant data meta-analysis from FINGER, MAPT, and Pre-DIVA. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2020;16(S10). https:\/\/doi.org\/10.1002\/alz.039287.","DOI":"10.1002\/alz.039287"},{"key":"875_CR42","doi-asserted-by":"crossref","unstructured":"Coley N, Hoevenaar-Blom MP, van Dalen JW, Moll van Charante EP, Kivipelto M, Soininen H, et al. Dementia risk scores as surrogate outcomes for lifestyle-based multidomain prevention trials\u2014rationale, preliminary evidence and challenges. Alzheimer\u2019s Dement. 2020; Wiley; [cited 2020 Sep 29]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32803862\/.","DOI":"10.1002\/alz.12169"},{"key":"875_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/JAD-140924","volume":"44","author":"M Vuorinen","year":"2015","unstructured":"Vuorinen M, Spulber G, Damangir S, Niskanen E, Ngandu T, Soininen H, et al. Midlife CAIDE Dementia Risk Score and dementia-related brain changes up to 30 years later on magnetic resonance imaging. J Alzheimer\u2019s Dis. 2015;44:93\u2013101 IOS Press.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"875_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2016.03.007","volume":"42","author":"D Enache","year":"2016","unstructured":"Enache D, Solomon A, Cavallin L, K\u00e5reholt I, Kramberger MG, Aarsland D, et al. CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia. Neurobiol Aging. 2016;42:124\u201331 Elsevier Inc.","journal-title":"Neurobiol Aging"},{"key":"875_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD-170092","volume":"59","author":"R Stephen","year":"2017","unstructured":"Stephen R, Liu Y, Ngandu T, Rinne JO, Kemppainen N, Parkkola R, et al. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. J Alzheimer\u2019s Dis. 2017;59:695\u2013705 IOS Press.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"875_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/joim.12736","volume":"283","author":"B Hooshmand","year":"2018","unstructured":"Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, M\u00e4kel\u00e4 M, et al. CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study. J Intern Med. 2018;283:597\u2013603 Wiley (10.1111).","journal-title":"J Intern Med"},{"key":"875_CR47","doi-asserted-by":"publisher","unstructured":"O'Brien JT, Firbank MJ, Ritchie K, Wells K, Williams GB, Ritchie CW, Su L. Association between midlife dementia risk factors and longitudinal brain atrophy: the PREVENT-Dementia study. J Neurol Neurosurg Psychiatry. 2020;91(2):158\u201361. https:\/\/doi.org\/10.1136\/jnnp-2019-321652. Epub 2019 Dec 5.","DOI":"10.1136\/jnnp-2019-321652"},{"key":"875_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11682-017-9789-5","volume":"13","author":"N Cherbuin","year":"2019","unstructured":"Cherbuin N, Shaw ME, Walsh E, Sachdev P, Anstey KJ. Validated Alzheimer\u2019s Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s. Brain Imaging Behav. 2019;13:65\u201374 Springer New York LLC.","journal-title":"Brain Imaging Behav"},{"key":"875_CR49","doi-asserted-by":"crossref","unstructured":"Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association. Alzheimers Dement. 2013;9 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23360977\/. [cited 2020 Dec 9].","DOI":"10.1016\/j.jalz.2013.01.002"},{"issue":"14","key":"875_CR50","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1212\/WNL.0b013e31828ab370","volume":"80","author":"S Kaffashian","year":"2013","unstructured":"Kaffashian S, Dugravot A, Elbaz A, Shipley MJ, Sabia S, Kivim\u00e4ki M, et al. Predicting cognitive decline: a dementia risk score vs the Framingham vascular risk scores. Neurology. 2013;80(14):1300\u20136. https:\/\/doi.org\/10.1212\/WNL.0b013e31828ab370.","journal-title":"Neurology."},{"key":"875_CR51","doi-asserted-by":"publisher","unstructured":"Li SS, Zheng J, Mei B, Wang HY, Zheng M, Zheng K. Correlation study of Framingham risk score and vascular dementia: An observational study. Medicine (Baltimore). 2017;96(50):e8387. https:\/\/doi.org\/10.1097\/MD.0000000000008387.","DOI":"10.1097\/MD.0000000000008387"},{"key":"875_CR52","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.neurobiolaging.2015.07.023","volume":"36","author":"G Viticchi","year":"2015","unstructured":"Viticchi G, Falsetti L, Buratti L, Boria C, Luzzi S, Bartolini M, et al. Framingham risk score can predict cognitive decline progression in Alzheimer\u2019s disease. Neurobiol Aging. 2015;36:2940\u20135 Elsevier Inc.; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26279114\/.","journal-title":"Neurobiol Aging"},{"key":"875_CR53","doi-asserted-by":"publisher","unstructured":"Gourley D, Pasha EP, Kaur SS, Haley AP, Tanaka H. Association of Dementia and Vascular Risk Scores With Cortical Thickness and Cognition in Low-risk Middle-aged Adults. Alzheimer Dis Assoc Disord. 2020;34(4):313\u20137. https:\/\/doi.org\/10.1097\/WAD.0000000000000392.","DOI":"10.1097\/WAD.0000000000000392"},{"key":"875_CR54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-191284","volume":"75","author":"S Torres","year":"2020","unstructured":"Torres S, Alexander A, O\u2019Bryant S, Medina LD. Cognition and the predictive utility of three risk scores in an ethnically diverse sample. J Alzheimer\u2019s Dis. 2020;75:1049\u201359 IOS Press BV; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32390625\/.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"875_CR55","doi-asserted-by":"crossref","unstructured":"Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic impact goal through 2020 and beyond. Circulation. 2010:586\u2013613 [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20089546\/.","DOI":"10.1161\/CIRCULATIONAHA.109.192703"},{"key":"875_CR56","doi-asserted-by":"publisher","first-page":"l4414","DOI":"10.1136\/bmj.l4414","volume":"366","author":"S Sabia","year":"2019","unstructured":"Sabia S, Fayosse A, Dumurgier J, Schnitzler A, Empana J-P, Ebmeier KP, et al. Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study. BMJ. 2019;366:l4414 Available from: http:\/\/www.bmj.com\/content\/366\/bmj.l4414.abstract.","journal-title":"BMJ"},{"key":"875_CR57","doi-asserted-by":"crossref","unstructured":"Zeki Al Hazzouri A, Haan MN, Neuhaus JM, Pletcher M, Peralta CA, L\u00f3pez L, et al. Cardiovascular risk score, cognitive decline, and dementia in older Mexican Americans: the role of sex and education. J Am Heart Assoc. 2013;2 [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23608609\/.","DOI":"10.1161\/JAHA.113.004978"},{"key":"875_CR58","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-190925","volume":"73","author":"T Rundek","year":"2020","unstructured":"Rundek T, Gardener H, Dias Saporta AS, Loewenstein DA, Duara R, Wright CB, et al. Global vascular risk score and CAIDE Dementia Risk Score predict cognitive function in the Northern Manhattan Study. J Alzheimers Dis. 2020;73:1221\u201331 NLM (Medline). [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31884476\/.","journal-title":"J Alzheimers Dis"},{"key":"875_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-190830","volume":"73","author":"W Tarraf","year":"2020","unstructured":"Tarraf W, Kaplan R, Daviglus M, Gallo LC, Schneiderman N, Penedo FJ, et al. Cardiovascular risk and cognitive function in middle-aged and older Hispanics\/Latinos: results from the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). J Alzheimer\u2019s Dis. 2020;73:103\u201316 IOS Press; [cited 2020 Nov 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31771064\/.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"875_CR60","doi-asserted-by":"publisher","unstructured":"Stephen R, Soininen H. Biomarker validation of a dementia risk prediction score. Nat Rev Neurol. 2020;16(3):135\u20136. https:\/\/doi.org\/10.1038\/s41582-020-0316-8.","DOI":"10.1038\/s41582-020-0316-8"},{"key":"875_CR61","doi-asserted-by":"publisher","unstructured":"Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4(2):363\u201381. https:\/\/doi.org\/10.2147\/vhrm.s1839.","DOI":"10.2147\/vhrm.s1839"},{"key":"875_CR62","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/alz.12123","volume":"16","author":"M Kivipelto","year":"2020","unstructured":"Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, et al. World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimer\u2019s Dement. 2020;16:1078\u201394 Wiley. [cited 2020 Sep 29]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32627328\/.","journal-title":"Alzheimer\u2019s Dement"},{"key":"875_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55\u201363 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25560714\/. American College of Physicians; [cited 2020 Nov 23].","journal-title":"Ann Intern Med"},{"key":"875_CR64","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2019: Attitudes to dementia. London: Alzheimer\u2019s Disease International; 2019."},{"key":"875_CR65","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/jgs.14834","volume":"65","author":"CRL Beishuizen","year":"2017","unstructured":"Beishuizen CRL, Coley N, van Charante EP, van Gool WA, Richard E, Andrieu S. Determinants of dropout and nonadherence in a dementia prevention randomized controlled trial: the Prevention of Dementia by Intensive Vascular Care Trial. J Am Geriatr Soc. 2017;65:1505\u201313 Available from: https:\/\/doi.org\/10.1111\/jgs.14834.","journal-title":"J Am Geriatr Soc"},{"key":"875_CR66","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jalz.2019.03.005","volume":"15","author":"N Coley","year":"2019","unstructured":"Coley N, Ngandu T, Lehtisalo J, Soininen H, Vellas B, Richard E, et al. Adherence to multidomain interventions for dementia prevention: data from the FINGER and MAPT trials. Alzheimer\u2019s Dement. 2019;15:729\u201341 Wiley. Available from: https:\/\/doi.org\/10.1016\/j.jalz.2019.03.005.","journal-title":"Alzheimer\u2019s Dement"},{"key":"875_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12877-020-1493-4","volume":"20","author":"A Rosenberg","year":"2020","unstructured":"Rosenberg A, Coley N, Soulier A, Kulmala J, Soininen H, Andrieu S, et al. Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial. BMC Geriatr. 2020;20:99 BioMed Central Ltd. [cited 2020 Nov 23]. Available from: https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-020-1493-4.","journal-title":"BMC Geriatr"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00875-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00875-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00875-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:16:15Z","timestamp":1636121775000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00875-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00875-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The paper was amended to add a DOI in references part of the Brain Health Services series.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GBF reports grants from Alzheimer Forum Suisse, Acad\u00e9mie Suisse des Sciences M\u00e9dicales, Avid Radiopharmaceuticals, Biogen, GE International, Guerbert, Association Suisse pour la Recherche sur l\u2019Alzheimer, IXICO, Merz Pharma, Nestl\u00e9, Novartis, Piramal, Roche, Siemens, Teva Pharmaceutical Industries, Vifor Pharma, and Alzheimer\u2019s Association; he has received personal fees from AstraZeneca, Avid Radiopharmaceuticals, Elan Pharmaceuticals, GE International, Lundbeck, Pfizer, and TauRx Therapeutics.JLM is currently a full-time employee of Lundbeck, has previously served as a consultant or at advisory boards for the following for-profit companies, or has given lectures in symposia sponsored by the following for-profit companies: Roche Diagnostics, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, and ProMIS Neurosciences.PS has received consultancy fees (paid to the institution) from AC Immune, Alkermes, Alnylam, Anavex, Biogen, Brainstorm Cell, Cortexyme, Denali, EIP, ImmunoBrain Checkpoint, GemVax, Genentech, Green Valley, Novartis, Novo Noridisk, PeopleBio, Renew LLC, and Roche. He is a PI of studies with AC Immune, CogRx, FUJI-film\/Toyama, IONIS, UCB, and Vivoryon. He serves on the board of the Brain Research Center.The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}